반응식
[Cl:1][C:2]1[S:6][C:5]([NH:7][C:8](=[O:23])[N:9]([C@H:16]2[CH2:21][CH2:20][C@H:19]([CH3:22])[CH2:18][CH2:17]2)[CH:10]2[CH2:15][CH2:14][NH:13][CH2:12][CH2:11]2)=[N:4][CH:3]=1.[C:24]([NH:27][C:28]1[CH:37]=[CH:36][C:31]([S:32](Cl)(=[O:34])=[O:33])=[CH:30][CH:29]=1)(=[O:26])[CH3:25]>>[Cl:1][C:2]1[S:6][C:5]([NH:7][C:8](=[O:23])[N:9]([CH:10]2[CH2:11][CH2:12][N:13]([S:32]([C:31]3[CH:30]=[CH:29][C:28]([NH:27][C:24](=[O:26])[CH3:25])=[CH:37][CH:36]=3)(=[O:34])=[O:33])[CH2:14][CH2:15]2)[C@H:16]2[CH2:21][CH2:20][C@H:19]([CH3:22])[CH2:18][CH2:17]2)=[N:4][CH:3]=1참가 물질
3
실험 절차
Prepared in a similar manner to Example 554 using 3-(5-chloro-thiazol-2-yl)-1-(trans-4-methyl-cyclohexyl)-1-piperidin-4-yl-urea and N-acetylsulfanilyl chloride.
출처 및 근거
- ORD 기록
- ord-27c08ca87d624d8aa2056d2012ff5c93
- 출처 데이터셋
- uspto-grants-2012_09
- 특허 번호
- US08263634B2
연결된 노트
불러오는 중…